Annual EBITDA
-$36.71 M
-$23.29 M-173.66%
31 December 2023
Summary:
Onconetix annual earnings before interest, taxes, depreciation & amortization is currently -$36.71 million, with the most recent change of -$23.29 million (-173.66%) on 31 December 2023. During the last 3 years, it has fallen by -$35.09 million (-2167.25%). ONCO annual EBITDA is now -4072.64% below its all-time high of -$879.70 thousand, reached on 01 December 2019.ONCO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$13.69 M
-$3.07 M-28.93%
30 June 2024
Summary:
Onconetix quarterly earnings before interest, taxes, depreciation & amortization is currently -$13.69 million, with the most recent change of -$3.07 million (-28.93%) on 30 June 2024. Over the past year, it has dropped by -$8.62 million (-169.75%). ONCO quarterly EBITDA is now -4119.82% below its all-time high of -$324.50 thousand, reached on 01 March 2021.ONCO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$51.53 M
-$7.04 M-15.83%
30 June 2024
Summary:
Onconetix TTM earnings before interest, taxes, depreciation & amortization is currently -$51.53 million, with the most recent change of -$7.04 million (-15.83%) on 30 June 2024. Over the past year, it has dropped by -$33.74 million (-189.68%). ONCO TTM EBITDA is now -12641.30% below its all-time high of -$404.40 thousand, reached on 01 December 2020.ONCO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -173.7% | -169.8% | -189.7% |
| 3 y3 years | -2167.3% | -1150.9% | -1870.7% |
| 5 y5 years | - | - | - |
ONCO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2167.3% | at low | -1150.9% | +38.1% | -1870.7% | at low |
| 5 y | 5 years | -4072.6% | at low | -4119.8% | +38.1% | <-9999.0% | at low |
| alltime | all time | -4072.6% | at low | -4119.8% | +38.1% | <-9999.0% | at low |
Onconetix EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$13.69 M(+28.9%) | -$51.53 M(+15.8%) |
| Mar 2024 | - | -$10.62 M(-52.0%) | -$44.48 M(+21.2%) |
| Dec 2023 | -$36.71 M(+173.7%) | -$22.14 M(+336.1%) | -$36.71 M(+106.4%) |
| Sept 2023 | - | -$5.08 M(-23.7%) | -$17.79 M(+7.3%) |
| June 2023 | - | -$6.65 M(+133.7%) | -$16.58 M(+16.8%) |
| Mar 2023 | - | -$2.84 M(-11.5%) | -$14.19 M(+5.8%) |
| Dec 2022 | -$13.41 M | - | - |
| Dec 2022 | - | -$3.22 M(-16.8%) | -$13.41 M(+17.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$3.86 M(-9.3%) | -$11.40 M(+32.1%) |
| June 2022 | - | -$4.26 M(+106.0%) | -$8.63 M(+67.3%) |
| Mar 2022 | - | -$2.07 M(+72.1%) | -$5.16 M(+51.1%) |
| Dec 2021 | -$3.41 M(+110.8%) | -$1.20 M(+9.8%) | -$3.41 M(+30.5%) |
| Sept 2021 | - | -$1.09 M(+38.4%) | -$2.61 M(+72.0%) |
| June 2021 | - | -$791.00 K(+143.8%) | -$1.52 M(+108.5%) |
| Mar 2021 | - | -$324.50 K(-19.8%) | -$728.90 K(+80.2%) |
| Dec 2020 | -$1.62 M(+84.0%) | -$404.40 K | -$404.40 K |
| Dec 2019 | -$879.70 K | - | - |
FAQ
- What is Onconetix annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Onconetix?
- What is Onconetix annual EBITDA year-on-year change?
- What is Onconetix quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Onconetix?
- What is Onconetix quarterly EBITDA year-on-year change?
- What is Onconetix TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Onconetix?
- What is Onconetix TTM EBITDA year-on-year change?
What is Onconetix annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ONCO is -$36.71 M
What is the all time high annual EBITDA for Onconetix?
Onconetix all-time high annual earnings before interest, taxes, depreciation & amortization is -$879.70 K
What is Onconetix annual EBITDA year-on-year change?
Over the past year, ONCO annual earnings before interest, taxes, depreciation & amortization has changed by -$23.29 M (-173.66%)
What is Onconetix quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ONCO is -$13.69 M
What is the all time high quarterly EBITDA for Onconetix?
Onconetix all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$324.50 K
What is Onconetix quarterly EBITDA year-on-year change?
Over the past year, ONCO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$8.62 M (-169.75%)
What is Onconetix TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ONCO is -$51.53 M
What is the all time high TTM EBITDA for Onconetix?
Onconetix all-time high TTM earnings before interest, taxes, depreciation & amortization is -$404.40 K
What is Onconetix TTM EBITDA year-on-year change?
Over the past year, ONCO TTM earnings before interest, taxes, depreciation & amortization has changed by -$33.74 M (-189.68%)